Donald Trump officially got the keys back to the White House earlier this week - and his return to power could have an impact on NZX-listed businesses.
Fisher & Paykel Healthcare produces medical devices sold in the US, and it's likely the incoming tariffs could leave an impact.
Milford Asset Management's Jeremy Hutton explains further.
LISTEN ABOVE

Gavin Grey: UK correspondent on the upcoming court ruling on Marine Le Pen
04:04

Shane Solly: Harbour Asset Management expert on the 'volatile' state of AI-based investments
03:33

Louise Tanguay: Sleep Store co-founder and director on the company turning 20
06:24